Aom-0765 (Hangzhou Adamerck)

N/A

Report date: 2025/03/25 14:15:43
NME

Base Information

Drug NameAom-0765 (Hangzhou Adamerck)
Drug Alias NameAom0765Aom-0765
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulatorsSodium channels blockers
TargetsGamma-aminobutyric acid A receptorSodium channels
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Adamerck Pharmlabs Inc
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Adamerck Pharmlabs Inc
Inactive CompaniesN/A
Active IndicationsAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A